Antiviral therapy for chronic hepatitis C : past, present, and future

スポンサーリンク

概要

• 論文の詳細を見る
• 2006-01-01

著者

• HAYASHI Norio

  Department of Biochemistry, Tohoku University School of Medicine

• Takehara Tetsuo

  Department Of Gastroenterology And Hepatology Osaka University Graduate School Of Medicine

• Takehara Tetsuo

  大阪大学 医学系研究科消化器内科

• Takehara Tetsuo

  Department Of Gastroenterology And Hepatology (k1) Osaka University Graduate School Of Medicine

• Hayashi Norio

  Department Of Gastroenterology And Hepatology Osaka University Graduate School Of Medicine

• Hayashi Norio

  大阪大学 医学系研究科消化器内科学

• Hayashi Norio

  Department Of Biochemistry Tohoku University School Of Medicine

• Hayashi Norio

  Department Of Biochemistry School Of Medicine Tohoku University

• TAKEHARA Tetsuo

  Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine

関連論文

• Guidelines for the antiviral therapy of hepatitis C virus carriers with normal serum aminotransferase based on platelet counts
• The Promoter of Mouse Transcription Repressor bach1 Is Regulated by Sp1 and Trans-Activated by Bach^1
• Conserved Structure, Regulatory Elements, and Transcriptional Regulation from the GATA-1 Gene Testis Promoter^1
• Multi-Slice Computed Tomography, a New Device for Percutaneous Coronary Intervention for Chronic Total Occluded Lesion(Coronary Revascularization, PTCA/Stent/DCA/Rotablator/New Device 11 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulatio
• Stent Expansion Index in Native Coronary Arteries with Multi-slice Intravascular Ultrasound Analysis(Coronary Revascularization, PTCA/Stent/DCA/Rotablator/New Device 11 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• Coronary Stent Perforation High Risk Sign in Intravascular Ultrasound, Japanese Registry Study(Coronary Revascularization, PTCA/Stent/DCA/Rotablator/New Device 13 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• Vogt-Koyanagi-Harada disease occurring during interferon alpha therapy for chronic hepatitis C
• A novel therapeutic strategy with anti-CD9 antibody in gastric cancers
• Lamivudine-to-entecavir switching treatment in type B chronic hepatitis patients without evidence of lamivudine resistance
• Adiponectin prevents progression of steatohepatitis in mice by regulating oxidative stress and Kupffer cell phenotype polarization
• Factors contributing to antiviral effect of adefovir dipivoxil therapy added to ongoing lamivudine treatment in patients with lamivudine-resistant chronic hepatitis B
• Effect of interferon α-2b plus ribavirin therapy on incidence of hepatocellular carcinoma in patients with chronic hepatitis
• Serum levels of soluble major histocompatibility complex (MHC) class I-related chain A in patients with chronic liver diseases and changes during transcatheter arterial embolization for hepatocellular carcinoma
• Early emergence of entecavir-resistant hepatitis B virus in a patient with hepatitis B virus/human immunodeficiency virus coinfection
• Initial viral response is the most powerful predictor of the emergence of YMDD mutant virus in chronic hepatitis B patients treated with lamivudine
• Early decline of hemoglobin can predict progression of hemolytic anemia during pegylated interferon and ribavirin combination therapy in patients with chronic hepatitis C
• Clinical Significance of High-Molecular Weight Form of Adiponectin in Male Patients With Coronary Artery Disease
• Early decline of hemoglobin correlates with progression of ribavirin-induced hemolytic anemia during interferon plus ribavirin combination therapy in patients with chronic hepatitis C
• Reduced expression and functional impairment of Toll-like receptor 2 on dendritic cells in chronic hepatitis C virus infection
• OE-350 The Influence of Wire Cross Pattern on Subsequent Outcome in CTO-PCI(Coronary Revascularization, PTCA/Stent/DCA/Rotablator/New Device 13 (IHD) : OE44)(Oral Presentation (English))
• OE-348 Optimal Stenting in the Situation of LCX Jail(Coronary Revascularization, PTCA/Stent/DCA/Rotablator/New Device 13 (IHD) : OE44)(Oral Presentation (English))
• Molecular Pathogenesis of Viral Hepatitis
• Should aged patients with chronic hepatitis C be treated with interferon and ribavirin combination therapy?
• The significance of interferon and ribavirin combination therapy followed by interferon monotherapy for patients with chronic hepatitis C in Japan
• Juvenile hepatocellular carcinoma with congestive liver cirrhosis
• Interferon therapy for aged patients with chronic hepatitis C : improved survival in patients exhibiting a biochemical response
• Expression of Rab5a in hepatocellular carcinoma : Possible involvement in epidermal growth factor signaling
• Changes in gene expression profile by HCV core protein in cultured liver cells : analysis by DNA array assay
• IS HELICOBACTER PYLORI-INDUCED ENLARGED FOLD GASTRITIS A HIGH-RISK FACTOR FOR GASTRIC CARCINOMA?
• Roles of double-balloon endoscopy in the diagnosis and treatment of Crohn's disease : a multicenter experience
• Foods and beverages in relation to urothelial cancer : Case-control study in Japan
• Cultured bone marrow cell local implantation accelerates healing of ulcers in mice
• Serum HCV RNA levels during early phase of recombinant interferon alfa-2a (Roferon A) therapy for chronic hepatitis C and efficacy of short-term therapy with earlier loss of viremia
• Effectiveness of real-time virtual sonography-guided radiofrequency ablation treatment for patients with hepatocellular carcinomas
• Hypervascular hepatocellular carcinoma : Combined dynamic MDCT and SPIO-enhanced MRI versus combined CTHA and CTAP
• Restoration of gut motility in Kit-deficient mice by bone marrow transplantation
• Suppressor of cytokine signaling-1 ameliorates dextran sulfate sodium-induced colitis in mice
• New chemotherapy for patients with advanced hepatocellular carcinoma : Pilot study of β-interferon and doxorubicin one-shot intra-arterial chemotherapy
• Triple therapy of initial high-dose interferon with ribavirin and amantadine for patients with chronic hepatitis C
• 5-Aminolevulinate Synthase Expression and Hemoglobin Synthesis in a Human Myelogenous Leukemia Cell Line^1
• Predictive values of amino acid sequences of the core and NS5A regions in antiviral therapy for hepatitis C : a Japanese multi-center study
• α-ガラクトシルセラミドをパルスした樹状細胞の肝内投与により肝腫瘍は抑制される
• Expression of GATA transcription factors in myelogenous and lymphoblastic leukemia cells
• Semiautomated volumetry of the cerebrum, cerebellum-brain stem, and temporal lobe on brain magnetic resonance images
• Adiponectin deficiency enhanced the severity of cerulein-induced chronic pancreatitis in mice
• Role of the Heme Regulatory Motif in the Heme-Mediated Inhibition of Mitochondrial Import of 5-Aminolevulinate Synthase
• Changes in virus loads and precore mutations in chronic hepatitis B patients treated with 4 weeks of daily interferon alfa-2a therapy
• Antiviral therapy for chronic hepatitis C : past, present, and future
• Measuring immunity in viral hepatitis
• The Effect of Cytokines on the Differentiation of an Eosinophilic Leukemia Cell Line (EoL - 1) is Associated with Down Regulation of c-myc Gene Expression
• Fas and Fas ligand in human hepatocellular carcinoma
• Management of hepatitis C ; Report of the Consensus Meeting at the 45th Annual Meeting of the Japan Society of Hepatology (2009)
• Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis C virus infection for the fiscal year 2008 in Japan
• Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis B virus infection for the fiscal year 2008 in Japan
• Development of a Method for Reconstructing Three-dimensional Data from Axial, Sagittal, and Coronal MR Images
• STAT3 signaling within hepatocytes is required for anemia of inflammation in vivo
• Adipocytokines and liver disease
• Molecular Pathogenesis of Viral Hepatitis
• Bcl-xL阻害薬ABT-737はソラフェニブと併用した時に肝癌細胞のアポトーシスを誘導し増殖を抑制する
• Absence of invariant natural killer T cells deteriorates liver inflammation and fibrosis in mice fed high-fat diet
• Distinct susceptibility of dendritic cell subsets to hepatitis C virus infection : a plausible mechanism of dendritic cell dysfunction
• Innate immunity in hepatitis C virus infection : Interplay among dendritic cells, natural killer cells and natural killer T cells
• Accumulation of refractory factors for pegylated interferon plus ribavirin therapy in older female patients with chronic hepatitis C
• SHORT-TERM OUTCOMES OF ENDOSCOPIC SUBMUCOSAL DISSECTION (ESD) FOR EARLY GASTRIC NEOPLASM : MULTICENTER SURVEY BY OSAKA UNIVERSITY ESD STUDY GROUP
• Factors predictive of sustained virological response following 72 weeks of combination therapy for genotype 1b hepatitis C
• Endoscopic submucosal dissection as a treatment for gastric noninvasive neoplasia : a multicenter study by Osaka University ESD Study Group
• Plasmablastic Extramedullary Plasmacytoma Associated with Epstein-Barr Virus Arising in an Immunocompetent Patient with Multiple Myeloma
• The efficacy of extended treatment with pegylated interferon plus ribavirin in patients with HCV genotype 1 and slow virologic response in Japan
• Efficacy of re-treatment with pegylated interferon plus ribavirin combination therapy for patients with chronic hepatitis C in Japan
• Differential alteration of CD56^ and CD56^ natural killer cells in frequency, phenotype, and cytokine response in chronic hepatitis C virus infection
• Efficacy of pegylated interferon plus ribavirin combination therapy for hepatitis C patients with normal ALT levels : a matched case-control study
• Dynamics of regulatory T cells and plasmacytoid dendritic cells as immune markers for virological response in pegylated interferon-α and ribavirin therapy for chronic hepatitis C patients
• Long-term effect of lamivudine treatment on the incidence of hepatocellular carcinoma in patients with hepatitis B virus infection
• Reducing Peg-IFN doses causes later virologic response or no response in HCV genotype 1 patients treated with Peg-IFN alfa-2b plus ribavirin
• Reply to the letter by L. Czako et al. regarding "Endoscopic submucosal dissection as a treatment for gastric noninvasive neoplasia : a multicenter study by Osaka University ESD Study Group"
• Hepatitis B virus reactivation associated with temozolomide for malignant glioma : a case report and recommendation for prophylaxis
• Simultaneous R2* and Liver Fat-fraction Measurement Using Modulus and Real Multiple Gradient-echo with Low-field MRI
• Organ Assimilation of Peptides
• Immunopathogenesis of Hepatitis C Virus Infection: Multifaceted Strategies Subverting Innate and Adaptive Immunity
• Guideline on the use of new anticancer drugs for the treatment of Hepatocellular Carcinoma 2010 update
• Conserved Structure, Regulatory Elements, and Transcriptional Regulation from the GATA-1 Gene Testis Promoter.
• Incidence of hepatocellular carcinoma in HCV-infected patients with normal alanine aminotransferase levels categorized by Japanese treatment guidelines
• Association of enhanced activity of indoleamine 2,3-dioxygenase in dendritic cells with the induction of regulatory T cells in chronic hepatitis C infection
• Adiponectin negatively correlates with alcoholic and non-alcoholic liver dysfunction : Health check-up study of Japanese men
• Conditional knockout of heparin-binding epidermal growth factor-like growth factor in the liver accelerates carbon tetrachloride-induced liver injury in mice
• Fibrosis score consisting of serum markers successfully predicts pathological fibrotic stages of chronic hepatitis B

もっと見る 閉じる

スポンサーリンク